Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
Over the last decade, poxviral vectors emerged as a mainstay approach for the induction of T cell-mediated immunity by vaccination, and their suitability for human use has led to widespread clinical testing of candidate vectors against infectious intracellular pathogens and cancer. In contrast, poxv...
Main Authors: | Draper, S, Cottingham, MG, Gilbert, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2013
|
Registos relacionados
-
Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.
Por: de Cassan, S, et al.
Publicado em: (2013) -
Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
Por: Alcock, R, et al.
Publicado em: (2010) -
Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
Por: Orubu, T, et al.
Publicado em: (2012) -
Poxviral Ankyrin Proteins
Por: Michael H. Herbert, et al.
Publicado em: (2015-02-01) -
Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
Por: Naif Khalaf Alharbi
Publicado em: (2019-01-01)